Corcept Therapeutics Inc XNAS: CORT

Expensive Performer

Download real time

69.37 -1.97 (-2.76%)

40.88% Fall from 52W High

551.8K

XNAS Volume

XNAS 04 Sep, 2025 5:30 PM (EDT)

Corcept Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents